Novo Nordisk has expanded its social media efforts, launching a new Twitter account for its US business.

It joins the Danish pharma company's existing accounts on the social network, which focus on corporate sustainability, graduate recruitment, and government affairs and public policy.

Its most note-worthy US social media initiative to date has been its sponsorship of Race with Insulin, which is pharma's first – and, so far, only – branded Twitter account.

Run by Indy car driver, and Novo-paid spokesman, Charlie Kimball, who has type I diabetes, the Twitter account's background currently features branding for the NovoLog Flexpen.

Novo's new Twitter account will be run by its US media relations and corporate communications director Ken Inchausti and focus on “news and views on diabetes and chronic disease for US audiences”.

• Links to Novo's new Twitter account and its existing social media initiatives can be found in the Digital Handbook's pharma social media directory

Digital inspiration for pharma on mobile, social media, strategy, best practice, regulations and more